Two Sigma Investments »

Kyverna Therapeutics shares owned by Two Sigma Investments

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Two Sigma Investments from 13F filings

Historical chart of Two Sigma Investments investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Two Sigma Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Two Sigma Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $518k 21k 24.84

More positions owned by Two Sigma Investments

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Micron Technology (MU)
Netflix (NFLX)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Paypal Holdings (PYPL)
Crowdstrike Hldgs Cl A (CRWD)
Bristol Myers Squibb (BMY)
Pepsi (PEP)
Robinhood Mkts Com Cl A (HOOD)
Humana (HUM)
Wal-Mart Stores (WMT)
Occidental Petroleum Corporation (OXY)
Gilead Sciences (GILD)

View all positions for Two Sigma Investments

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics